Morphine, Buprenorphine, and Other Drugs Market, by Drug (Morphine, Buprenorphine, Noscapine, Thebaine, and Etrophine), by Application (Pain Management, Opioid Addiction Treatment, and Others), by Route Of Administration (Injectable, Oral, and Transdermal

Morphine, Buprenorphine, and Other Drugs Market, by Drug (Morphine, Buprenorphine, Noscapine, Thebaine, and Etrophine), by Application (Pain Management, Opioid Addiction Treatment, and Others), by Route Of Administration (Injectable, Oral, and Transdermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Morphine, buprenorphine, and other similar drugs are known as opioid drugs. Opium is dark brown, resinous material obtained from poppy capsule called opium containing alkaloids. Opioids include morphine, buprenorphine, noscapine, thebaine, etrophine, and other similar substances. Morphine is principle alkaloid in opium and is described prototype of this class of drugs. Opioids have sedative and analgesic effects, and are commonly used for pain management. Opioids are commonly indicated in traumatic, visceral, ischaemic, postoperative burn, and cancer pain. The growth in the market can be primarily attributed to the growing prevalence of cancer worldwide.
Market Dynamics
The key drivers contributing to the global morphine, buprenorphine and other drug market's growth is the increase in prevalence of diseases such as cancer, chronic pain (post-surgical pain, lower back pain), arthritis, and fibromyalgia. Several narcotic drugs are recommended for the management of moderate to severe pain in cancer patients. For instance, according to Centers for Disease Control and Prevention (CDC) cancer is one of leading causes of deaths in the U.S. Furthermore, according to U.S. Cancer Statistics of 2021 in 2018 1,708,923 Americans were diagnosed with cancer. Thus, owing to prevalence of cancer and use of opioids for treatment of cancer is expected to drive the market growth.
Key features of the study:
This report provides an in-depth analysis of the morphine, buprenorphine, and other drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the morphine, buprenorphine and other drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Purdue Pharma, Sun Pharmaceuticals, Pfizer Inc. , West Ward Pharmaceuticals, Teva Pharmaceuticals, Piramal Pharmaceuticals, Hikama Pharmaceuticals, Indivior PLC, Oreoxo AB, Camurus AB, and Novartis
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The morphine, buprenorphine, and other drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global morphine, buprenorphine, and other drugs market
Detailed Segmentation:
Global Morphine, Buprenorphine and Other Drugs Market, By Drug:
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
Global Morphine, Buprenorphine and Other Drugs Market, By Application:
Pain Management
Opioid Addiction Treatment
Others
Global Morphine, Buprenorphine and Other Drugs Market, By Route Of Administration:
Injectable
Oral
Transdermal
Global Morphine, Buprenorphine and Other Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Global Morphine, Buprenorphine and Other Drugs, By Region:
North America
By Drugs
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration
Injectable
Oral
Transdermal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
By Country
U.S.
Canada
Latin America
By Drug
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration
Injectable
Oral
Transdermal
, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration
Injectable
Oral
Transdermal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration
Injectable
Oral
Transdermal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration
Injectable
Oral
Transdermal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug
Morphine
Buprenorphine
Noscapine
Thebaine
Etrophine
By Application
Pain Management
Opioid Addiction Treatment
Other
By Route Of Administration
Injectable
Oral
Transdermal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Purdue Pharma*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Sun Pharmaceuticals
Pfizer Inc.
West Ward Pharmaceuticals
Teva Pharmaceuticals
Piramal Pharmaceuticals
Hikama Pharmaceuticals
Indivior PLC
Oreoxo AB
Camurus AB
Novartis

“*” marked represents similar segmentation in other categories in the respective section.